Article Text

Download PDFPDF
Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
  1. James Leon Hartley1,
  2. Neil Bailey2,
  3. Asheesh Sharma3 and
  4. Howida Shawki4
  1. 1Nephrology, Royal Liverpool University Hospital, Liverpool, UK
  2. 2Nephrology, Warrington and Halton Teaching Hospitals NHS Foundation Trust, Warrington, UK
  3. 3Nephrology, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK
  4. 4Histopathology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK
  1. Correspondence to Dr James Leon Hartley; james.hartley{at}rlbuht.nhs.uk

Abstract

We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome.

  • COVID-19
  • immunological products and vaccines
  • renal system
  • vaccination/immunisation
  • nephrotic syndrome

This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors JLH, as the main author of the article, composed the case series and compiled the case reports, and was responsible for investigations, management and follow-up. NB, as the second author, compiled literature review and references. AS, as the third author, oversaw preparation of the manuscript for publication and aided with literature review. HS provided histopathology slides and comments.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.